A study in humans identified the mir-3605-3p as differentially expressed in whole blood between patients with and without recurrent myocardial infarction after percutaneous coronary intervention, with significance observed in both initial and replication cohorts (p < 0.05) [Onuoha et al. DOI:10.1111/cts.13307].